Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-06 10:55 am Purchase | 2023-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FRANKLIN RESOURCES INC BEN | 4,640,651 9.500% | 510,514![]() (+12.36%) | Filing History |
2023-12-14 4:04 pm Purchase | 2023-12-04 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Cormorant Asset Management, LP | 6,038,235 12.360% | 6,038,235![]() (New Position) | Filing History |
2023-12-08 5:28 pm Sale | 2023-12-04 | 13D | EyePoint Pharmaceuticals, Inc. EYPT | EW Healthcare Partners, L.P. | 2,337,786 5.000% | -1,312,606![]() (-35.96%) | Filing History |
2023-09-11 11:15 am Sale | 2023-08-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FRANKLIN RESOURCES INC BEN | 4,130,137 11.800% | -1,644,372![]() (-28.48%) | Filing History |
2023-08-30 5:22 pm Sale | 2019-03-28 | 13D | EyePoint Pharmaceuticals, Inc. EYPT | EW Healthcare Partners, L.P. | 3,650,392 10.400% | -540,004![]() (-12.89%) | Filing History |
2023-05-01 4:23 pm Purchase | 2023-04-21 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Cormorant Global Healthcare Master Fund LP | 3,200,000 9.330% | 3,200,000![]() (New Position) | Filing History |
2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | RA Capital Management, L.P. | 3,408,706 9.990% | 1,801,847![]() (+112.13%) | Filing History |
2023-02-13 10:23 am Sale | 2022-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | SUVRETTA CAPITAL MANAGEMENT LLC | 3,411,210 9.990% | -70,899![]() (-2.04%) | Filing History |
2023-01-31 11:44 am Purchase | 2022-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FRANKLIN RESOURCES INC BEN | 5,774,509 16.900% | 827,344![]() (+16.72%) | Filing History |
2022-02-11 4:24 pm Purchase | 2021-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | SUVRETTA CAPITAL MANAGEMENT LLC | 3,482,109 9.990% | 1,886,945![]() (+118.29%) | Filing History |
2022-02-10 09:13 am Purchase | 2021-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,950,000 5.750% | 450,000![]() (+30.00%) | Filing History |
2022-02-03 2:12 pm Purchase | 2021-12-31 | 13G | FIGS, Inc. FIGS | FRANKLIN RESOURCES INC BEN | 8,333,476 5.500% | 8,333,476![]() (New Position) | Filing History |
2022-02-03 2:02 pm Purchase | 2021-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FRANKLIN RESOURCES INC BEN | 4,947,165 14.600% | 3,533,218![]() (+249.88%) | Filing History |
2021-08-13 4:31 pm Purchase | 2021-08-03 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | RA Capital Management, L.P. | 1,606,859 5.600% | 1,606,859![]() (New Position) | Filing History |
2021-07-26 5:21 pm Purchase | 2021-07-14 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | SUVRETTA CAPITAL MANAGEMENT LLC | 1,595,164 5.600% | 1,595,164![]() (New Position) | Filing History |
2021-02-12 4:06 pm Purchase | 2021-02-04 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,500,000 5.230% | 1,500,000![]() (New Position) | Filing History |
2021-02-01 2:18 pm Purchase | 2020-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FRANKLIN RESOURCES INC BEN | 1,413,947 7.800% | 1,413,947![]() (New Position) | Filing History |
2021-01-21 6:21 pm Purchase | 2020-12-31 | 13D | EyePoint Pharmaceuticals, Inc. EYPT | Ocumension Therapeutics | 3,010,722 16.600% | 3,010,722![]() (New Position) | Filing History |
2020-11-10 10:47 am Purchase | 2020-10-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FRANKLIN RESOURCES INC BEN | 1,413,750 10.600% | 1,413,750![]() (New Position) | Filing History |